lobbying_activities: 3183963
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3183963 | 24827107-3a43-4b59-9905-2be5713280fd | Q2 | BLUEBIRD STRATEGIES | 401105447 | THERMO FISHER SCIENTIFIC INC | 2024 | second_quarter | HCR | Pioneering Antimicrobial Subscriptions to End Upsurging Resistance PASTEUR Act and issues related to sepsis treatment and antibiotic stewardship. CMS SEP-1 measure implementation. CDC AMR activities. Issues related to health insurance coverage and regulation of FDA cleared biomarkers to predict preeclampsia. | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2024-06-03T14:20:05-04:00 |